drugset / Trial / NCT01049243
A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
Phase 4
Completed
20 enrolled
Wake Forest University Health Sciences
Medicis Pharmaceutical Corporation · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to better understand how fluocinonide cream 0.1% (Vanos®) works when people use it to treat atopic dermatitis for just a few days.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-09
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluocinonide | Other / unclassified | 0.1 % | — |